EXACOS CARBON: Describing the Greenhouse Gas Emissions of Healthcare Resource Utilization by Frequency and Severity of COPD Exacerbation in England
John Bell(AstraZeneca (Switzerland)), Jennifer K Quint(Imperial College London), Constantinos Kallis(Imperial College London), Christer Janson(Uppsala University), Omar S. Usmani(Guy's and St Thomas' NHS Foundation Trust), Alex Wilkinson(Lister Hospital), Clémentine Nordon(AstraZeneca (United Kingdom)), Hannah Whittaker(Imperial College London), Emily L. Graul(Emory University)
Cited by 5
Related Papers
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
|European Heart Journal|2022|3.6k
The European Community Respiratory Health Survey: what are the main results so far?
|European Respiratory Journal|2001|454
Overuse of short-acting β<sub>2</sub>-agonists in asthma is associated with increased risk of exacerbation and mortality: a nationwide cohort study of the global SABINA programme
|European Respiratory Journal|2020|447
Incidence of Chronic Obstructive Pulmonary Disease in a Cohort of Young Adults According to the Presence of Chronic Cough and Phlegm
|American Journal of Respiratory and Critical Care Medicine|2006|308
Asthma control in Europe: A real-world evaluation based on an international population-based study
|Journal of Allergy and Clinical Immunology|2007|276